During the past decade, Skaraborgs sjukhus conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skaraborgs sjukhus" #1 sponsor was "ETOP IBCSG Partners Foundation" with 3 trials, followed by "Göteborg University" with 2 trials sponsored, "AbbVie" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Dilafor AB" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skaraborgs sjukhus" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Uppsala University Hospital" with 2 trials as a collaborator, "Capio S:t Görans Hospital" with 1 trials as a collaborator, "Clinical Trials Sweden, Forum South" with 1 trials as a collaborator and "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Skaraborgs sjukhus" are "Breast Cancer" (3 trials), "Acute Ischaemic Stroke" (1 trials), "Coronary Artery Disease" (1 trials), "Covid-19" (1 trials) and "Hidradenitis Suppurativa" (1 trials). Many other conditions were trialed in "Skaraborgs sjukhus" in a lesser frequency.

Most popular intervention types in "Skaraborgs sjukhus" are "Drug" (7 trials), "Other" (3 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "Adalimumab" (1 trials), "CT or PET scans" (1 trials), "Cetuximab" (1 trials) and "DF 01" (1 trials). Other intervention names were less common.

The vast majority of trials in "Skaraborgs sjukhus" are 9 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Skaraborgs sjukhus". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Skaraborgs sjukhus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Skaraborgs sjukhus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".